(Q31893934)

4 July 2017

Tumour necrosis factor inhibitors reduce the acute-phase response in hapten-induced colitis (English)

1 reference

4 July 2017

0 references

1 reference

Armstrong AM

1

1 reference

4 July 2017

Foulkes R

2

1 reference

4 July 2017

Jennings G

3

1 reference

4 July 2017

Gannon C

4

1 reference

4 July 2017

Kirk SJ

5

1 reference

4 July 2017

Gardiner KR

6

1 reference

4 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

British Journal of Surgery

4 July 2017

1 reference

4 July 2017

88

1 reference

4 July 2017

2

1 reference

4 July 2017

235-240

1 reference

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea

4 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Effect of gamma interferon on cachectin expression by mononuclear phagocytes. Reversal of the lpsd (endotoxin resistance) phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

Cachectin and tumour necrosis factor as two sides of the same biological coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2001.01646.X

10.1046/J.1365-2168.2001.01646.X

21 January 2018

Identifiers

DOI

1 reference

4 July 2017

1 reference